Skip to main content

Align Technology company profile

  • ALGN · Nasdaq
  • Medical devices
  • Health Care Supplies
  • S&P 500
$168.32+0.81%Close 13 Nov 2026 · Market value $11.84B

About Align Technology

Align Technology is a global medical device company engaged in designing, manufacturing and marketing Invisalign clear aligners for treating malocclusions, Vivera retainers, iTero intraoral scanners and related dental services, and exocad CAD/CAM software. Its products are sold mainly through a dedicated sales force to orthodontists, general dental practitioners, dental laboratories and dental support organizations, with sales agents and distributors used in certain countries. Clear aligners account for approximately 80% of worldwide net revenues, and Imaging Systems and CAD/CAM Services for the remaining 20% in the year ended December 31, 2025. The company also sells Invisalign accessory products through online, retail and pharmacy channels. Regional headquarters are located in Raleigh, Rotkreuz and Singapore, serving the Americas, EMEA and APAC.

A summary of the business section of the company's latest annual report, filed 27 Feb 2026.

Company facts

TickerALGN · Nasdaq
SectorMedical devices
IndustryHealth Care Supplies
IndexS&P 500
Fiscal year ends31 December
Reporting currencyUSD
CIK1097149
Latest annual report10-K, filed 27 Feb 2026

Officers and directors

NameRoleShares ownedLatest Form 4
Joseph M. HoganPresident and CEO · Director266K · < 1%Shares withheld for tax, 20 Feb 2026
Joseph LacobDirector136K · < 1%Option exercise, 20 May 2026
C. Raymond Larkin, Jr.Director27.5K · < 1%Option exercise, 20 May 2026
Andrea L. SaiaDirector17.3K · < 1%Option exercise, 20 May 2026
Kevin J. DallasDirector16.2K · < 1%Option exercise, 20 May 2026
Stuart HockridgeEVP, GLOBAL HR14.9K · < 1%Option exercise, 20 Feb 2026
John F. MoriciEVP, CHIEF FINANCIAL OFFICER13.5K · < 1%Option exercise, 20 Feb 2026
Julie ColettiEVP, CHIEF LEGAL & REGULATORY11.4K · < 1%Shares withheld for tax, 20 Feb 2026
Susan E. SiegelDirector10.7K · < 1%Option exercise, 20 May 2026
Anne M. MyongDirector9.8K · < 1%Option exercise, 20 May 2026
George J. MorrowDirector8.3K · < 1%Option exercise, 20 May 2026
Kevin T. ConroyDirector3.6K · < 1%Option exercise, 20 May 2026
Mojdeh PoulDirector3.6K · < 1%Option exercise, 20 May 2026
Britt VitaloneDirector1.4KOption exercise, 20 May 2026

Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.

ALGN in the terminal

The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.